http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 29 Oct 2024 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Press+Releases/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html <p class="bwalignc"> <i>– Industry veteran to serve as independent director, strengthening the board and bringing extensive leadership, executive and governance experience to Cartography as it builds out its oncology platform and pipeline -</i> </p> <p> SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcartography.bio%2F&amp;esheet=54143391&amp;newsitemid=20241029358268&amp;lan=en-US&amp;anchor=Cartography+Biosciences%2C+Inc.&amp;index=1&amp;md5=abf5373e3946d380b1416df95c66c880" shape="rect">Cartography Biosciences, Inc.</a>, an oncology company advancing a pipeline of antibody therapeutics that more precisely target tumors, today announced the appointment of Troy E. Wilson, Ph.D., J.D., as an independent director. Dr. Wilson, a 25-year veteran of the biopharma industry, is President, CEO and co-founder of Kura Oncology (Nasdaq: KURA) and has served as chairman of its http://www.streetinsider.com/Business+Wire/Cartography+Announces+Appointment+of+Troy+Wilson%2C+Ph.D.%2C+J.D.%2C+to+its+Board+of+Directors/23891304.html Tue, 29 Oct 2024 08:00:00 -0400 A.03295816 A.29393384 A.34221934 AMAM KURA O.02316246 O.15127974 O.19968560 O.20113531 O.22645058 RNA